Hikma Pharmaceuticals PLC HIK shares shed 3.16% to £19.02 Friday, on what proved to be an all-around rough trading session ...

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of final data from the RESTORE open-label/switch ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.05% to £19.14 Wednesday, on what proved to be an all-around rough ...

U.K. equities were higher at the close on Tuesday, as gains in the Industrial Transportation, General Retailers and Beverage ...

Global stock markets experienced an uptick on Tuesday as investors held their breath for the US interest rate decision. The ...

The biggest risers on the FTSE 100 were Kingfisher, up 32.6p to 322.9p, easyJet, up 30.1p to 517.4p, JD Sports Fashion, up ...

IBD is a chronic inflammation of the intestine characterised by severe stomach pain and diarrhoea affecting nearly 5 million ...

Application error: a client-side exception has occurred (see the browser console for more information).

U.S sterile injectables market is estimated to be valued at US$ 131.8 billion in 2022 and expected to exhibit a CAGR of 9.3% over the forecast period 2022-2030 ...

European markets ended weak on Tuesday, weighed down by losses in automobile, pharmaceutical and biotech sectors. The mood was ...

(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Xellia's FDF ...